A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 29; p. v26
Main Authors	Bang, Y., Van Cutsem, E., Fuchs, C., Ohtsu, A., Tabernero, J., Ilson, D., Hyung, W., Strong, V., Goetze, T., Yoshikawa, T., Tang, L., Hwang, P., Shitara, K.
Format	Journal Article
Language	English
Published	England Elsevier Ltd 01.06.2018
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdy151.095